Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
AIDS (London, England)|October 31, 1997
Risk factors for prevalent and incident HIV infection in a cohort of volunteer blood donors in Harare, Zimbabwe: implications for blood safetyW McFarland, D Mvere, D Katzenstein
The Journal of Infectious Diseases|April 16, 1998
Human immunodeficiency virus type 1 RNA shedding in the female genital tractC Goulston, W McFarland, D Katzenstein
AIDS Care|March 15, 2011
Operational challenges in delivering CD4 diagnostics in sub-Saharan AfricaL Thairu, D Katzenstein, D Israelski
Social Science & Medicine (1982)|November 21, 1998
Sexual behaviour and risk assessment of HIV seroconvertors among urban male factory workers in ZimbabweS Ray, A Latif, R Machekano, et al.
AIDS Research and Human Retroviruses|July 1, 1990
International collaborative study to compare assays for antibodies that neutralize human immunodeficiency virusL Vujcic, D Katzenstein, M Martin, et al.
Transfusion|May 1, 1998
Risk factors for HIV seropositivity among first-time blood donors in ZimbabweW McFarland, D Mvere, R Shamu, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 1, 1997
Measuring quality of life in early HIV disease: the modular approachW R Lenderking, M A Testa, D Katzenstein, et al.
The Journal of Infectious Diseases|October 1, 1996
Human immunodeficiency virus reverse transcriptase codon 215 mutations diminish virologic response to didanosine-zidovudine therapy in subjects with non-syncytium-inducing phenotypeM Holodniy, D Katzenstein, L Mole, et al.
The Journal of Infectious Diseases|February 18, 1998
Association between human immunodeficiency virus and herpes simplex virus type 2 seropositivity among male factory workers in ZimbabweL Gwanzura, W McFarland, D Alexander, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1992
Enhancement of human immunodeficiency virus (HIV)-specific CD4+ and CD8+ cytotoxic T-lymphocyte activities in HIV-infected asymptomatic patients given recombinant gp160 vaccineS K Kundu, D Katzenstein, L E Moses, et al.
Pageof 5